Veracyte sells diagnostic tests, many for cancer, to physicians and healthcare providers from South San Francisco, California. It last closed at $25.13 on Nov 20, up 0.36% on the day. The next earnings report for VCYT is expected around Mon, Jan 11, 2027. For the quarter ended Sep 2026, VCYT reported EPS of $0.38 on revenue of $151.8M, with revenue up 15.1% from a year ago. Over its last 8 reports the stock moved an average of 19.7% the session after earnings. Over the last 12 months VCYT insiders bought $0 of stock on the open market and sold $19.2M, according to SEC Form 4 filings.
AI Auto Pilots
Is VCYT in one of our AI portfolios?
Five AI traders run real portfolios in the open, with every decision logged. Create a free account to see if they hold VCYT.
Close to close, the session after each report, adjusted for splits. Past moves are no guide to the next one.
StreetAlpha callBullish64%
OPTIONS
+2
DARK POOL
+1
HISTORY
0
TECHNICAL
+1
StreetAlpha's call on VCYTStart your 7 day free trial to see StreetAlpha's call before the report, with the options flow, dark pool, history and technical scores behind it.Sign up freeSign in
VCYT · as of the Nov 20 close · updated each morning
Downtrend, oversold
The stock is 39% below its 20 day and 61% below its 50 day average. It is 67% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 31), oversold. The nearest support is the Pivot at $25.09, and the nearest resistance the Pivot R1 at $25.64.
Short trendBearish
Long trendBearish
MomentumWeak
StretchOversold
VolatilityHigh, 11.3%/day
Key levels
$60.9152 week high+142.4%
$45.99Swing high (Sep 3)+83.0%
$44.86100 day average+78.5%
$42.08200 day average+67.4%
$40.4150 day average+60.8%
$34.9520 day average+39.1%
$25.64Pivot R1+2.0%
$25.13Last close
$25.09Pivot−0.2%
$24.57Pivot S1−2.2%
$23.27Swing low (Nov 16)−7.4%
$21.9152 week low−12.8%
Indicators
RSI (14)
31.28
Weak, oversold below 30
Neutral
MACD
-5.64
Below its signal line
Bearish
Stochastic
10.8
Near the bottom of its range
Oversold
ADX (14)
41.6
Strong downtrend
Williams %R
-89.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-53.7
Oversold below −100, overbought above 100
Neutral
Rate of change
+4.0%
Change over 10 sessions
Bullish
ATR (14)
$2.83
Typical daily range, 11.3% of price
MA 10Above
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Pullback inside a longer uptrend, nearing oversold
Short trendBearish
Long trendBullish
MomentumWeak
StretchNear oversold
VolatilityHigh, 26.2%/day
Key levels
$60.9152 week high+142.4%
$45.99Swing high (Sep 3)+83.0%
$44.86100 day average+78.5%
$42.08200 day average+67.4%
$40.4150 day average+60.8%
$34.9520 day average+39.1%
$25.64Pivot R1+2.0%
$25.13Last close
$25.09Pivot−0.2%
$24.57Pivot S1−2.2%
$23.27Swing low (Nov 16)−7.4%
$21.9152 week low−12.8%
Indicators
RSI (14)
33.67
Weak, oversold below 30
Neutral
MACD
-3.31
Below its signal line
Bearish
Stochastic
8.5
Near the bottom of its range
Oversold
ADX (14)
22.0
Weak trend
Williams %R
-89.6
Oversold below −80, overbought above −20
Oversold
CCI (20)
-210.3
Oversold below −100, overbought above 100
Oversold
Rate of change
−38.5%
Change over 10 sessions
Bearish
ATR (14)
$6.58
Typical daily range, 26.2% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for VCYT
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how VCYT did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record. Free with an account.
November seasonalityHow VCYT usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
AI Day Trader
Watch Claude day trade the open, live.
Every session it trades SPY, QQQ, IWM and two daily stock picks, with each call logged before the move.
Whale options flow for VCYTHow many large options trades hit VCYT, the bullish and bearish split, and every trade with strike, premium and expiry are shown to AI Starter and AI Pro members.Sign up freeSign in
No whale options trades in VCYT in the last 90 days.
From SEC Form 4 filings by VCYT's officers, directors and 10% owners. Open market buys and sales only; option exercises, gifts, awards and tax withholding are left out. Not investment advice.
AI Auto Pilots
Paper trading
StreetAlpha runs autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether VCYT is in one of them and how their past VCYT trades turned out.
From official House and Senate disclosure reports, filed up to 45 days after the trade and shown in dollar ranges. Not investment advice. Use limited by 5 U.S.C. 13107. About this data
About Veracyte
Veracyte is a diagnostic company based in South San Francisco, California. It develops and sells tests, many of them for cancer, that help physicians make decisions about patient care. Its best-known product is the Prosigna breast cancer test, which is available in international markets and runs on the nCounter Analysis System. The company also offers thyroid testing services and performs many of its tests in its own laboratories for physicians and healthcare providers.